Dibiglim P 15mg/2mg Tablet

Pioglitazone (15mg) + Glimepiride (2mg) Primary uses of : Type 2 diabetes
Manufacturer: Novartis India Ltd
*
₹ 45.00 incl tax
Composition Pioglitazone (15mg) + Glimepiride (2mg)
Potentially Unsafe With Alcohol
Side Effect Common Hypoglycemia (low blood sugar level), Edema (swelling), Weight gain, Bone fracture, Blurred vision, Respiratory tract infection.
How to works How Dibiglim P Tablet works Dibiglim P 15mg/2mg Tablet is a combination of two antidiabetic medicines: Pioglitazone and glimepiride. Pioglitazone is a thiazolidinedione which works by increasing the body's sensitivity to insulin. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas in order to lower the blood glucose. Together, they provide better control of blood sugar.